7 min read
Keystone Symposia Fellow Spotlight: Dr. Esteban Vazquez-Hidalgo
By Emma Wabel
We are proud to feature Keystone Symposia Fellow Esteban Vazquez-Hidalgo, PhD, a Postdoctoral Scholar...
David Soto-Pantoja, PhD, investigates cell surface receptor CD47 as an immunotherapy for breast, lung, head and neck cancers and melanoma. Through clinical trials and animal model collaborations, he explores the effects of CD47 targeting on tumor cell bioenergetics, with the goal of developing anti-cancer therapeutics that inhibit tumor growth and prevent chemotherapy-related cardiac toxicity.
Research Area(s):
Research Keywords:
Mentor: Juanita L. Merchant, MD, PhD
Nov 17, 2026 by Emma Wabel
By Emma Wabel
We are proud to feature Keystone Symposia Fellow Esteban Vazquez-Hidalgo, PhD, a Postdoctoral Scholar...
Sep 24, 2026 by Emma Wabel
By Emma Wabel
We are proud to feature Keystone Symposia Fellow Alex Chaim, PhD, an Assistant Professor in the...